Home » Stocks » CRXM

Gene Biotherapeutics Inc. (CRXM)

Stock Price: $0.0511 USD 0.0011 (2.20%)
Updated Jul 27, 2021 1:51 PM EDT - Market closed
Market Cap 2.70M
Revenue (ttm) n/a
Net Income (ttm) 866,675
Shares Out 14.49M
EPS (ttm) 0.06
PE Ratio 0.85
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 27
Last Price $0.0511
Previous Close $0.0500
Change ($) 0.0011
Change (%) 2.20%
Day's Open 0.0478
Day's Range 0.0460 - 0.0551
Day's Volume 496,466
52-Week Range 0.0245 - 0.1079

News

There are no news available yet.

About CRXM

Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. It is also developing Generx for ischemia-related cardiovascular and cerebr... [Read more...]

Industry
Biotechnology
Founded
2003
CEO
Christopher Reinhard
Employees
4
Stock Exchange
OTCMKTS
Ticker Symbol
CRXM
Full Company Profile

Financial Performance

Financial Statements